$BRQL
brooqLy, Inc.

2022 Q4 Form 10-Q Financial Statement

#000147793222008714 Filed on November 18, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $201.00 $661.00
YoY Change -81.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $142.6K $49.59K
YoY Change 133.36% 78.85%
Operating Profit -$142.4K -$48.93K
YoY Change 137.38% 76.46%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $48.00
YoY Change -100.04%
Pretax Income -$142.3K -$48.93K
YoY Change -20.91% 76.46%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$142.3K -$48.93K
YoY Change 137.3% 76.46%
Net Earnings / Revenue -70816.92% -7401.82%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 22.31M shares 23.31M shares 21.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.00 $1.328K $5.543K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $204.00 $204.00
Receivables
Other Receivables
Total Short-Term Assets $205.00 $1.532K
YoY Change -99.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $129.5K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $129.5K $139.0K
YoY Change 162.87%
TOTAL ASSETS
Total Short-Term Assets $205.00 $1.532K
Total Long-Term Assets $129.5K $139.0K
Total Assets $129.7K $140.5K
YoY Change 63.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $118.5K $64.80K
YoY Change 630.6%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $140.4K $97.98K
YoY Change 543.55%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $140.4K $97.98K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$480.5K -$547.3K -$404.9K
YoY Change 66.07%
Common Stock $2.259K $2.232K
YoY Change 0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.67K $42.51K $10.05K
YoY Change
Total Liabilities & Shareholders Equity $129.7K $140.5K $76.90K
YoY Change 63.14%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$142.3K -$48.93K
YoY Change 137.3% 76.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Revenues
Revenues
201 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
33184 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5597 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
97982 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21811 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2232 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2257 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001854526
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56399
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
dei Entity Registrant Name
EntityRegistrantName
brooqLy, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2265420
dei Entity Address Address Line1
EntityAddressAddressLine1
10101 S. Roberts Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 209
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22564982 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22314982 shares
CY2021 brooqly Warrants Issued To Accredited Investor
WarrantsIssuedToAccreditedInvestor
1000000 shares
CY2022Q1 brooqly Purchase Of Warrants During Period
PurchaseOfWarrantsDuringPeriod
1000000 shares
CY2022Q3 brooqly Common Stock Share Outstanding
CommonStockShareOutstanding
22314982 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Entity Address City Or Town
EntityAddressCityOrTown
Palos Hill
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60465
dei City Area Code
CityAreaCode
224
dei Local Phone Number
LocalPhoneNumber
789-6673
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22314982 shares
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-142342 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22314982 shares
CY2022Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
84800 shares
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
502765 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
432740 usd
CY2022Q3 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
0 usd
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
88000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-547289 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42508 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140490 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
201 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
61103 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-142390 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-59985 usd
CY2022Q3 us-gaap Other Income
OtherIncome
48 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
0 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
120000 usd
us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
120000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142342 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-179985 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-179985 usd
us-gaap Profit Loss
ProfitLoss
-257980 usd
us-gaap Profit Loss
ProfitLoss
-212636 usd
CY2022Q3 brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2021Q3 brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
CY2022Q3 brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
22303025 shares
CY2021Q3 brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
20436869 shares
brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
22182748 shares
brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
13508139 shares
us-gaap Profit Loss
ProfitLoss
-257980 usd
us-gaap Profit Loss
ProfitLoss
-212636 usd
us-gaap Interest Expense Other
InterestExpenseOther
120000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
27587 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-91800 usd
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
34707 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-34707 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
78000 usd
brooqly Shares To Be Issued For Cash
SharesToBeIssuedForCash
20000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
98000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
162500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-28507 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
95870 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30035 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1328 usd
brooqly Reversal Of Warrants
ReversalOfWarrants
100000 usd
brooqly Reversal Of Warrants
ReversalOfWarrants
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57687 usd
CY2022Q1 brooqly Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
13000 usd
CY2022Q1 brooqly Reversal Of Warrants Amount
ReversalOfWarrantsAmount
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-66712 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3976 usd
CY2022Q2 brooqly Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
55000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-48926 usd
CY2022Q3 brooqly Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
10000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
80000 usd
CY2022Q3 brooqly Shares To Be Issued
SharesToBeIssued
84800 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-142342 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
42508 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4925 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4925 usd
CY2021Q2 brooqly Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
25400 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-27726 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-7251 usd
CY2021Q3 brooqly Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
137101 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
49497 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
120000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-59985 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
239362 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
976 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 brooqly Common Stock Share Issued
CommonStockShareIssued
22314982 shares
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
22564982 shares
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
265500 usd
CY2021Q4 brooqly Stockholders Equity Note Subscriptions Receivable1
StockholdersEquityNoteSubscriptionsReceivable1
88000 usd
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
247482 shares
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
49497 usd
CY2022Q1 brooqly Purchase Of Shares During Period
PurchaseOfSharesDuringPeriod
1000000 shares
CY2022Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.10
CY2022Q1 brooqly Desription Of Investment1
DesriptionOfInvestment1
The investment was in excess of $50,000 entitling the investor to receive shares and warrants at a reduced price instead of at $0.20 per share from those investors investing less than $50,000. The investor failed to pay $75,000 of the aggregate investment and the company has determined that the investor will not receive the benefit of the $0.10 per share price and its shares shall be calculated on the basis of $0.20 per share, for which there is an adjusted number of common shares (and no warrants), of 125,000 shares for the cash proceeds of $25,000 that the company received from the investor
CY2021Q4 brooqly Number Of Investors
NumberOfInvestors
3 integer
CY2022Q1 brooqly Investment Description
InvestmentDescription
Aggregate Investment; as such, the investment was calculated on the basis of $0.20 per share, for which there is an adjusted number of Common Stock Shares (and no warrants) of 125,000 shares, rather than the 1,000,000 shares. The difference of 875,000 shares (will be cancelled and returned to the Company’s treasury. resulting in a decrease of the Company’s outstanding shares by 875,000 shares
CY2021Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
0 usd
CY2021 brooqly Number Of Common Stock Sold
NumberOfCommonStockSold
2564982 shares
CY2021 brooqly Receipt From Sale Of Common Stock
ReceiptFromSaleOfCommonStock
265500 usd
CY2021 us-gaap Accounts Receivable Sale
AccountsReceivableSale
103000 usd
CY2021 brooqly Common Stock For Stock Base Compensation
CommonStockForStockBaseCompensation
247482 shares
CY2021 brooqly Common Stock For Stock Base Compensation Amount
CommonStockForStockBaseCompensationAmount
49497 usd
CY2021 us-gaap Profit Loss
ProfitLoss
212636 usd
CY2021 brooqly Ending Balance Of Stockholders Equity
EndingBalanceOfStockholdersEquity
57687 usd

Files In Submission

Name View Source Status
0001477932-22-008714-index-headers.html Edgar Link pending
0001477932-22-008714-index.html Edgar Link pending
0001477932-22-008714.txt Edgar Link pending
0001477932-22-008714-xbrl.zip Edgar Link pending
brooqly-20220930.xsd Edgar Link pending
brooqly_10q.htm Edgar Link pending
brooqly_ex311.htm Edgar Link pending
brooqly_ex312.htm Edgar Link pending
brooqly_ex321.htm Edgar Link pending
brooqly_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
brooqly-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brooqly-20220930_pre.xml Edgar Link unprocessable
brooqly-20220930_lab.xml Edgar Link unprocessable
brooqly-20220930_def.xml Edgar Link unprocessable
brooqly_10q_htm.xml Edgar Link completed